Deciphering Cancer Resistance: mechanisms, targets, and emerging therapies

Deciphering Cancer Resistance: Mechanisms, Targets, and Emerging Therapies addresses the critical challenge of treatment resistance in oncology. Despite advancements in chemotherapy, radiotherapy, and targeted therapies, resistance remains a significant hurdle. This book provides a comprehensive examination of the cellular, molecular, and genetic mechanisms behind resistance, unveiling insights from cancer biology and genomics that inform novel therapeutic strategies. The book explores cutting-edge technologies like CAR-T cell therapy, nanotechnology, and artificial intelligence, highlighting their role in discovering new treatment modalities. It presents the latest preclinical and clinical data, including newly FDA-approved therapies, demonstrating their potential to improve patient outcomes. For academics, this resource consolidates the latest research and clinical developments, aiding researchers, clinicians, and students in staying updated with advancements. It serves as a guide for graduate studies and research, offering critical insights into drug development and targeted therapies for professionals in the pharmaceutical and biotechnology sectors, ultimately driving progress in cancer treatment.